Molecular Pathology and Molecular Markers of Ductal Carcinoma in-situ

E-ISSN： 1875-6301|8|3|197-204

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.8, Iss.3, 2012-08, pp. : 197-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Markers for the Diagnosis and Management of Ductal Carcinoma In Situ

By Polyak Kornelia

Journal of the National Cancer Institute Monographs, Vol. 2010, Iss. 41, 2010-10 ,pp. : 210-213

Oxford University Press

Access to resources Recommend Favorite

Rural-urban differences in radiation therapy for ductal carcinoma in-situ of the breast

By Schootman M. Aft R.

Breast Cancer Research and Treatment, Vol. 68, Iss. 2, 2001-07 ,pp. : 117-125

Springer Publishing Company

Access to resources Recommend Favorite

Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast

By Provenzano E. Hopper J.L. Giles G.G. Marr G. Venter D.J. Armes J.E.

European Journal of Cancer, Vol. 39, Iss. 5, 2003-03 ,pp. : 622-630

Elsevier

Access to resources Recommend Favorite

Immunohistochemical Evaluation of Multiple Biological Markers in Ductal Carcinoma In Situ of the Breast

By Perin T. Canzonieri V. Massarut S. Bidoli E. Rossi C. Roncadin M. Carbone A.

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1148-1155

Elsevier

Access to resources Recommend Favorite

Epidemiology of Ductal Carcinoma In Situ

By Kerlikowske Karla

Journal of the National Cancer Institute Monographs, Vol. 2010, Iss. 41, 2010-10 ,pp. : 139-141

Oxford University Press

Access to resources Recommend Favorite